Kailera Therapeutics, Inc.·3

Apr 16, 5:54 PM ET

CANADA PENSION PLAN INVESTMENT BOARD 3

3 · Kailera Therapeutics, Inc. · Filed Apr 16, 2026

Insider Transaction Report

Form 3
Period: 2026-04-16
Holdings
  • Series B Preferred Stock

    [F1][F2]
    (indirect: See the Footnote)
    Exercise: $0.00Common Stock (5,000,000 underlying)
Footnotes (2)
  • [F1]Each share of Series B Preferred Stock of the issuer is convertible into one share of the issuer's common stock any time at the option of the reporting person. The issuer's Series B Preferred Stock has no expiration date.
  • [F2]The securities reported herein are held directly by CPP Investment Board Private Holdings (4) Inc., a wholly-owned subsidiary of Canada Pension Plan Investment Board, and as such, Canada Pension Plan Investment Board is an indirect beneficial owner of such securities.

Documents

1 file
  • 3
    ownership.xmlPrimary

    3